Made for Mainstream Medicine    

Personalized, evidence-based cannabinoid care & safer, precisely-dosed products.

Supportive Oncologist-Led

The EO experience has been shaped by years of research and clinical experience in a supportive oncology setting. It’s customized to fit each patient, align with other treatment protocols and meds in use and provide valuable data to the patient’s entire care team.
Dr. Brooke Worster
EO Chief Medical Officer
Director, Supportive Oncology
Sidney Kimmel Cancer Center
What we provide

A Complete Solution

Expert Guidance
We provide two forms of supportive oncologist-led care:
  • Phone and text support if questions or concerns arise about products, dosing and side effects.
  • Personalized care plans specifying products, doses and times of use. All based on symptoms, relevant aspects of the medical record, others meds in use, daily schedule and ongoing feedback.
Optimal Products
Our federally legal, clinician-formulated products are:
  • Made with the high-quality, hemp-derived Delta-9 THC, CBD and proven supplements:
  • Purpose-designed for cancer-related pain, stress, sleep and appetite issues.
  • Provided in healthy, well-tolerated forms, including gummies, tinctures, inhalers and beverage shots.
  • Easy to obtain. They can be ordered online and shipped straight to the home like any other package.
Want to Learn More?
We’re here to answer your questions about EO and how easy it can be to refer your patients. Call 877-707-0706, email clinicians@eo.care or schedule a free consultation below.
Book Now Minimize
Care That Scales

Our digital health platform provides clinically responsible, personalized, adaptive product dose and use guidance - while generating valuable efficacy and cost of care data.

And it does so at low/no cost. So every American can access the guidance they need to use cannabinoids more safely and effectively.

Trusted by Physicians & Advocates

EO is recommended by clinicians at leading healthcare centers, including Mayo Clinic, Mount Sinai Hospital, Northwell Health, Penn Medicine and UVA Health - as well as by leading older adult and cancer advocacy organizations.

Clinical Efficacy

Cancer and treatment-related symptom intensity for EO care plan users as measured over time using broadly accepted PROMIS metrics. 50 is healthy adult baseline.

*3-point or greater reduction in PROMIS score. The data is sourced from over 100 cancer patients and older adults who utilized EO’s clinical care platform to manage their symptoms. PROMIS scores and activity difficulty levels were documented before beginning care and periodically throughout treatment to assess symptom changes. ER visits and any side effects were also monitored during the course of treatment, as well as any patient-reported reduction in prescription medications.

Cost of Care Impacts

Cancer patients using EO care plans reported fewer emergency room visits and reduced reliance on prescription medications.

$23,169

Estimated per patient annual cost of cancer symptom management.

$11,078

Estimated per patient annual cost of cancer symptom management with EO.

*The data is sourced from over 100 cancer patients and older adults who utilized EO’s clinical care platform to manage their symptoms. PROMIS scores and activity difficulty levels were documented before beginning care and periodically throughout treatment to assess symptom changes. ER visits and any side effects were also monitored during the course of treatment, as well as any patient-reported reduction in prescription medications.

See How EO Works
Meet EO. And cancer survivor Ethan Zohn.
Watch Video

See How EO Works

Meet EO. And cancer survivor Ethan Zohn.

Watch Video

Our Clinical Team Leads

CHIEF MEDICAL OFFICER

Brooke Worster, MD
“Cannabis can be a helpful tool in managing symptoms caused by cancer and its treatments. But too many patients don’t get the support they need to responsibly and optimally experience its benefits .”

CHIEF CANNABIS CLINICIAN

Ben Caplan, MD
“Cannabis is powerful medicine and comes with real benefits and risks. With more than 10 years advising thousands of patients, I know the right, ongoing guidance can make all the difference.”

GERIATRIC CLINICAL PHARMACIST

Emily Hajjar, PharmD, BCGP

CHIEF MEDICAL OFFICER

Brooke Worster, MD

CHIEF CANNABIS CLINICIAN

Ben Caplan, MD

GERIATRIC CLINICAL PHARMACIST

Emily Hajjar, PharmD, BCGP

Our Clinical Advisors

Clinical Advisor

Regina Benjamin, MD

Clinical Advisor

Jacob Strand, MD

Clinical Advisor

Greg Garber, MSW, LCSW